financetom
LZM
financetom
/
Materials
/
LZM
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Lifezone Metals LimitedLZM
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Lifezone Metals Limited operates as a metals company in the battery metals supply chain of extraction, processing, and recycling.

It supplies low-carbon and sulphur dioxide emission metals to the battery and EV markets. The company's products include nickel, copper, and cobalt.

Its flagship project is the Kabanga nickel project in North-West Tanzania. The company is based in Ramsey, Isle of Man.

Latest News >
AtkinsRealis Unit Reaches Framework Agreement to Support Deployment of Poland's First Small Modular Reactors
AtkinsRealis Unit Reaches Framework Agreement to Support Deployment of Poland's First Small Modular Reactors
Jun 28, 2024
10:47 AM EDT, 06/28/2024 (MT Newswires) -- Candu Energy Inc., an AtkinsRealis ( SNCAF ) company (ATRL.TO), Friday entered into a framework agreement with Orlen-Synthos Green Energy (OSGE) for the planned deployment of a fleet of GE Hitachi Nuclear Energy's BWRX-300 small modular reactors (SMRs) in Poland. Also, the company entered a teaming agreement with OSGE, Aecon ( AEGXF )...
--First of Long Island Keeps Quarterly Dividend at $0.21 per Share, Payable July 18 to Shareholders of Record July 10
--First of Long Island Keeps Quarterly Dividend at $0.21 per Share, Payable July 18 to Shareholders of Record July 10
Jun 28, 2024
10:44 AM EDT, 06/28/2024 (MT Newswires) -- Price: 10.11, Change: +0.32, Percent Change: +3.27 ...
Soleno Therapeutics Submits New Drug Application to FDA for Prader-Willi Syndrome Treatment
Soleno Therapeutics Submits New Drug Application to FDA for Prader-Willi Syndrome Treatment
Jun 28, 2024
10:44 AM EDT, 06/28/2024 (MT Newswires) -- Soleno Therapeutics ( SLNO ) said Friday it has submitted a new drug application to the US Food and Drug Administration for approval of DCCR (diazoxide choline) extended-release tablets for the treatment of Prader-Willi syndrome in patients aged 4 and older who have hyperphagia. The FDA has 60 days to decide if the...
IZEA Worldwide Launches $5 Million Share Buyback Plan
IZEA Worldwide Launches $5 Million Share Buyback Plan
Jun 28, 2024
10:46 AM EDT, 06/28/2024 (MT Newswires) -- IZEA Worldwide ( IZEA ) said Friday its board has approved a share buyback program under which the company may repurchase up to $5 million of its common shares from time to time. The program is subject to market conditions and the company's insider trading windows. Shares of IZEA ( IZEA ) were...
Copyright 2023-2026 - www.financetom.com All Rights Reserved